Skip to main content
    C

    Cadrenal Therapeutics, Inc. Common Stock (CVKD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.40
    -0.11 (-7.28%)

    Market Cap: $5.39M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Cadrenal Therapeutics, Inc. Common Stock (CVKD) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Cadrenal Therapeutics, Inc. Common Stock are Cardio Diagnostics Holdings (CDIO), SeaStar Medical Holding (ICU) and PharmaCyte Biotech (PMCB). By market cap, Cadrenal Therapeutics, Inc. Common Stock ranks 6th of the 13 companies on this page; Biocardia (BCDA) is the largest at $12.58M.

    Peer Comparison

    CVKD's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Cadrenal Therapeutics, Inc. Common Stock (CVKD)$5.39MN/AN/A0.0%N/A0.0%0.00%
    Cardio Diagnostics Holdings Inc (CDIO)$5.59MN/A348.9x0.0%N/A25.7%0.00%
    SeaStar Medical Holding Corporation (ICU)$4.46MN/A1.7x0.0%N/A82.0%0.00%
    PharmaCyte Biotech Inc (PMCB)$3.77MN/AN/A0.0%N/A0.0%0.00%
    Reviva Pharmaceuticals Holdings Inc. (RVPH)$4.63MN/AN/A0.0%-90.2%0.0%0.00%
    Kiora Pharmaceuticals Inc (KPRX)$5.44MN/A6.2x0.0%N/A0.0%0.00%
    Biocardia Inc (BCDA)$12.58MN/AN/A0.0%N/A-100.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    Theriva Biologics Inc. (TOVX)$6.61MN/A21.5x0.0%-52.3%0.0%0.00%
    VistaGen Therapeutics Inc (VTGN)$8.01MN/A3.4x0.0%N/A-46.5%0.00%
    Skye Bioscience, Inc. Common Stock (SKYE)$4.83MN/AN/A0.0%-3685.3%0.0%0.00%
    Creative Medical Technology Holdings Inc (CELZ)$4.01MN/AN/A0.0%N/A0.0%0.00%
    Curis Inc (CRIS)$2.97MN/A1.6x0.0%N/A-66.0%0.00%
    Peer median$4.73MN/A4.8x0.0%-90.2%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Cadrenal Therapeutics, Inc. Common Stock, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Cardio Diagnostics Holdings Inc (CDIO)
    Cardio Diagnostics Holdings Inc (CDIO) is a pioneering biotechnology firm focused on enhancing cardiovascular health through innovative diagnostic solutions.
    CDIO competitors
    SeaStar Medical Holding Corporation (ICU)
    SeaStar Medical Holding Corporation (ICU) is a forward-looking biotechnology company dedicated to innovating treatment solutions for chronic kidney disease via...
    ICU competitors
    PharmaCyte Biotech Inc (PMCB)
    PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United...
    PMCB competitors
    Reviva Pharmaceuticals Holdings Inc. (RVPH)
    Reviva Pharmaceuticals Holdings Inc. (RVPH) is a clinical-stage biopharmaceutical company dedicated to developing groundbreaking therapies for central nervous...
    RVPH competitors
    Kiora Pharmaceuticals Inc (KPRX)
    Kiora Pharmaceuticals Inc. is a clinical-stage biotechnology firm focused on developing innovative therapies for ocular diseases and neurodegenerative...
    KPRX competitors
    Biocardia Inc (BCDA)
    BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease.
    BCDA competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    Theriva Biologics Inc. (TOVX)
    Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need.
    TOVX competitors
    VistaGen Therapeutics Inc (VTGN)
    VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential...
    VTGN competitors
    Skye Bioscience, Inc. Common Stock (SKYE)
    Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops...
    SKYE competitors
    Creative Medical Technology Holdings Inc (CELZ)
    Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics...
    CELZ competitors
    Curis Inc (CRIS)
    Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States.
    CRIS competitors

    Frequently Asked Questions About CVKD

    Who are Cadrenal Therapeutics, Inc. Common Stock's main competitors?

    The companies most similar to Cadrenal Therapeutics, Inc. Common Stock include Cardio Diagnostics Holdings (CDIO), SeaStar Medical Holding (ICU), PharmaCyte Biotech (PMCB), Reviva Pharmaceuticals Holdings (RVPH) and Kiora Pharmaceuticals (KPRX), listed from the closest match.

    Who is Cadrenal Therapeutics, Inc. Common Stock's biggest competitor?

    Biocardia (BCDA) is the largest of the similar companies at $12.58M; Cardio Diagnostics Holdings (CDIO) is the closest match by business profile, size, sector and industry.

    How does CVKD stock compare with its competitors?

    CVKD's net margin is 0.0% against a peer median of 0.0%.

    Which of Cadrenal Therapeutics, Inc. Common Stock's competitors pays a higher dividend?

    Cadrenal Therapeutics, Inc. Common Stock pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Cadrenal Therapeutics, Inc. Common Stock bigger than its competitors?

    No. Cadrenal Therapeutics, Inc. Common Stock is 6th by market cap among the 13 companies on this page; the largest is Biocardia (BCDA) at $12.58M.